Patents-Review.com
ClassID:

97309 ⎘

C07K2318/00 - CPC Classification

Classification description:

Antibody mimetics or scaffolds

Sub-classes:
Recent Application in this class:
#1
20260103541
2026-04-16

Paracrine Adenoviral Delivery of Biomolecules

 #2
20260092119
2026-04-02

Anti-Inflammatory Polypeptides

 #3
20260070967
2026-03-12

AFFIBODY-BASED DUAL AFFINITY FUSION PROTEINS AND USES THEREOF

 #4
20260028397
2026-01-29

METHODS OF TREATING ANKYLOSING SPONDYLITIS

 #5
20250382361
2025-12-18

AFFIBODIES, HYDROGELS CONTAINING AFFIBODIES, AND USES THEREOF

 #6
20250361282
2025-11-27

ATRIAL NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES

 #7
20250327083
2025-10-23

Nucleic acid scaffolded artificial immune complexes

 #8
20250270519
2025-08-28

CHIMAERIC PROTEINS AND THERAPEUTIC AGENTS

 #9
20250257148
2025-08-14

ATP-Dependent Agonists of Immune Cells Function as Anticancer Agents

 #10
20250228955
2025-07-17

PLATFORM TECHNOLOGY FOR BISPECIFIC ANTIGENBINDING PROTEINS

 #11
20250215108
2025-07-03

ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS

 #12
20250154549
2025-05-15

GLYCOSYLTRANSFERASE VARIANT, AND METHOD OF PREPARING STEVIOL GLYCOSIDES USING SAME

 #13
20240327460
2024-10-03

NORA INHIBITORS AND METHODS OF USE

 #14
20240254229
2024-08-01

NOVEL DARPin BASED MULTI-SPECIFIC T-CELL ENGAGERS

 #15
20240207406
2024-06-27

METHODS AND COMPOSITIONS COMPRISING MHC CLASS I PEPTIDES

 #16
20240150475
2024-05-09

NOVEL DARPIN BASED CD123 ENGAGERS

 #17
20240010694
2024-01-11

HYDROGELS CONTAINING AFFIBODIES AND USES THEREOF

 #18
20230295306
2023-09-21

Anti-Inflammatory Polypeptides

 #19
20230272085
2023-08-31

Methods for reducing eosinophilic infiltration by administering an anti-interleukin-4 receptor (IL4R) antibody

 #20
20230072235
2023-03-09

PRO-MACROBODIES FOR THE ENHANCEMENT OF STRUCTURE RESEARCH

 #21
20230056271
2023-02-23

DARPin based multi-specific t-cell engagers

 #22
20220281991
2022-09-08

Anti-SIRPa antibodies and their therapeutic applications

 #23
20220276264
2022-09-01

DARPin REAGENTS THAT DISTINGUISH ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE SAMPLES

 #24
20220229072
2022-07-21

USE OF CD9 AS A BIOMARKER AND AS A BIOTARGET IN GLOMERULONEPHRITIS OR GLOMERULOSCLEROSIS

 #25
20220221795
2022-07-14

METHODS FOR DETECTING TRAUMATIC BRAIN INJURY

 #26
20220195037
2022-06-23

COMPOSITIONS AND METHODS FOR INHIBITING CANCER STEM CELLS

 #27
20220162300
2022-05-26

Methods of treating FGF21-associated disorders

 #28
20210396745
2021-12-23

LOW-COST DETECTION OF NOROVIRUS USING PAPER-BASED CELL-FREE SYSTEMS AND SYNBODY-BASED VIRAL ENRICHMENT

 #29
20210198671
2021-07-01

PROTECTED ANTIBODY-DRUG AND APTAMER-DRUG CONJUGATES

 #30
20210189011
2021-06-24

Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation

 #31
20210139555
2021-05-13

ATRIAL NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES

 #32
20210130472
2021-05-06

Anti-inflammatory polypeptides

 #33
20210101986
2021-04-08

Anti-inflammatory polypeptides

 #34
20210000971
2021-01-07

Fusion protein comprising glutathione-s-transferase and protein having binding affinity target cell or target protein, and use thereof

 #35
20200332014
2020-10-22

Methods of treating eosinophilic esophagitis by administering an antibody which inhibits interleukin-4 receptor (IL-4R)

 #36
20200241014
2020-07-30

DARPin reagents that distinguish Alzheimer's disease and Parkinson's disease samples

 #37
20200181241
2020-06-11

Ultralong complementarity determining regions and uses thereof

 #38
20200087392
2020-03-19

Methods of treating FGF21-associated disorders

 #39
20200054741
2020-02-20

PEPTIDE-BASED VACCINES, METHODS OF MANUFACTURING, AND USES THEREOF FOR INDUCING AN IMMUNE RESPONSE

 #40
20190285620
2019-09-19

Detection of norovirus using norovirus-specific toehold switches

 #41
20190262368
2019-08-29

Antibodies specific for LOX1 and use in treatment of cardiovascular disorders

 #42
20190218275
2019-07-18

Immunoglobulin constant region Fc receptor binding agents

 #43
20190194357
2019-06-27

Cysteine-optimized stradomers

 #44
20190169601
2019-06-06

RECOGNITION TAGS FOR TGASE-MEDIATED CONJUGATION

 #45
20190127477
2019-05-02

Anti-SIRPa antibodies and their therapeutic applications

 #46
20190125891
2019-05-02

COMPOSITIONS AND METHODS FOR TISSUE REPAIR

 #47
20190062398
2019-02-28

High avidity HPV T-cell receptors

 #48
20190040119
2019-02-07

Method for producing antibody

 #49
20190002544
2019-01-03

Blood-brain barrier permeable peptide compositions comprising a VAB domain of an anti-amyloid-beta camelid single-domain heavy-chain only antibody

 #50
20180364577
2018-12-20

Methods for detecting traumatic brain injury

 #51
20180354997
2018-12-13

Methods of producing glycosylated proteins

 #52
20180334668
2018-11-22

Triple-mode system for antibody maturation, surface display and secretion

 #53
20180334510
2018-11-22

Compositions and methods for modulating kinase activity

 #54
20180273616
2018-09-27

Compositions and methods for inhibiting cancer stem cells

 #55
20180222987
2018-08-09

Anti-CD3 antibodies, anti-CD123 antibodies and bispecific antibodies specifically binding to CD3 and/or CD123

 #56
20180215828
2018-08-02

SYNTHETIC ANTIBODY MIMIC PEPTIDES

 #57
20180186862
2018-07-05

Immunoglobulin constant region Fc receptor binding agents

 #58
20180179284
2018-06-28

Anti-inflammatory polypeptides

 #59
20180051087
2018-02-22

Anti-inflammatory polypeptides

 #60
20170334970
2017-11-23

Generating Targeted Sequence Diversity in Proteins

 #61
20170326199
2017-11-16

USE OF CASPASE-2 INHIBITORS TO TREAT AND PREVENT THE METABOLIC SYNDROME

 #62
20170306032
2017-10-26

Small antibody-like polypeptides that bind to EPHA2 receptor

 #63
20170304343
2017-10-26

Antibodies specific for LOX1 and use in treatment of cardiovascular disorders

 #64
20170283471
2017-10-05

MODIFIED MICROBIAL TOXIN RECEPTOR FOR DELIVERING AGENTS INTO CELLS

 #65
20170226514
2017-08-10

PREVENTION OF TUMOUR METASTASIS BY INHIBITION OF NECROPTOSIS

 #66
20170218049
2017-08-03

Immunoglobulin constant region Fc receptor binding agents

 #67
20170158736
2017-06-08

Compositions and methods for treating MRSA infections and for sensitizing MRSA to beta-lactam antibiotics

 #68
20170101474
2017-04-13

Synthetic antibody mimic peptides

 #69
20170044238
2017-02-16

Engineering of immunoglobulin domains

 #70
20170044080
2017-02-16

RADIOCONJUGATION METHOD

 #71
20170035902
2017-02-09

COMPOSITIONS AND METHODS FOR TISSUE REPAIR

 #72
20160362458
2016-12-15

Modified microbial toxin receptor for delivering agents into cells

 #73
20160355570
2016-12-08

Immunoglobulin constant region Fc receptor binding agents

 #74
20160347840
2016-12-01

Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof

 #75
20160331801
2016-11-17

USE OF CASPASE-2 INHIBITORS TO TREAT AND PREVENT THE METABOLIC SYNDROME

 #76
20160319024
2016-11-03

ANTI-INFLAMMATORY POLYPEPTIDES

 #77
20160319008
2016-11-03

Methods of treating wounds in a diabetic subject

 #78
20160310613
2016-10-27

METHODS AND COMPOSITIONS FOR OVERCOMING DRUG-RESISTANCE IN CANCER BY TARGETED DELIVERY OF PRO-DRUG-NANO-POLYMERS

 #79
20160200811
2016-07-14

Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation

 #80
20160166717
2016-06-16

Radiolabelling method

 #81
20160152718
2016-06-02

Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor

 #82
20150376280
2015-12-31

Anti-inflammatory polypeptides

 #83
20150376278
2015-12-31

USE OF A CD28 BINDING PHARMACEUTICAL SUBSTANCE FOR MAKING A PHARMACEUTICAL COMPOSITION WITH DOSE-DEPENDENT EFFECT

 #84
20150329850
2015-11-19

Generating targeted sequence diversity in proteins

 #85
20150284713
2015-10-08

Recognition tags for TGase-mediated conjugation

 #86
20150284463
2015-10-08

Bispecific HER2 ligands for cancer therapy

 #87
20150210756
2015-07-30

Compositions and methods for phagocyte delivery of anti-staphylococcal agents

 #88
20150094450
2015-04-02

Repebody for novel interleukin-6 and use thereof

 #89
20140377280
2014-12-25

Non-sialylated anti-inflammatory polypeptides

 #90
20140302072
2014-10-09

Non-natural MIC proteins

 #91
20140086871
2014-03-27

Ultralong complementarity determining regions and uses thereof

 #92
20120309941
2012-12-06

IMMUNOGLOBULIN CONSTANT REGION FC RECEPTOR BINDING AGENTS

 #93
20120251541
2012-10-04

Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation

 #94
20120219553
2012-08-30

USE OF A CD258 BINDING PHARMACEUTICAL SUBSTRANCE FOR MAKING A PHARMACEUTICAL COMPOSITION WITH DOSE-DEPENDENT EFFECT

 #95
20120172235
2012-07-05

Peptide libraries

 #96
20110311561
2011-12-22

Non-natural MIC proteins

 #97
20100291080
2010-11-18

Compositions and methods for tissue repair

 #98
20100266605
2010-10-21

USE OF A CD28 BINDING PHARMACEUTICAL SUBSTANCE FOR MAKING A PHARMACEUTICAL COMPOSITION WITH DOSE-DEPENDENT EFFECT

 #99
20100239633
2010-09-23

Immunoglobulin constant region FC receptor binding agents

 #100
20090226899
2009-09-10

Aptameric IgE peptides in a protein scaffold as an allergy vaccine

 #101
20060009382
2006-01-12

Use of a CD28 binding pharmaceutical substance for making a pharmaceutical composition with dose-dependent effect

 #102
20050202024
2005-09-15

Protein sequences containing antigenized antibodies for foot-and-mouth disease